Premium
Why could passive Immunoglobulin E antibody therapy be safe in clinical oncology?
Author(s) -
JensenJarolim E.,
Singer J.
Publication year - 2011
Publication title -
clinical and experimental allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.462
H-Index - 154
eISSN - 1365-2222
pISSN - 0954-7894
DOI - 10.1111/j.1365-2222.2011.03764.x
Subject(s) - medicine , antibody therapy , antibody , clinical oncology , immunology , oncology , cancer , monoclonal antibody
Cite this as : E. Jensen‐Jarolim and J. Singer, Clinical & Experimental Allergy , 2011 (41) 1337–1340.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom